Figures & data
Figure 1. (a) Differences in EQ-5D-5 L scores for control and treatment group between the pre-trial and post-trial surveys completed. An increase in EQ-5D-5 L score represents a higher self-rated quality of life for the individual. (b) Average percentage change in EQ5D5L VAS scores for control and treatment groups from the pre-trial and post-trial surveys completed. An increase in EQ5D5L VAS score represents a higher self-rated quality of life for the individual.
![Figure 1. (a) Differences in EQ-5D-5 L scores for control and treatment group between the pre-trial and post-trial surveys completed. An increase in EQ-5D-5 L score represents a higher self-rated quality of life for the individual. (b) Average percentage change in EQ5D5L VAS scores for control and treatment groups from the pre-trial and post-trial surveys completed. An increase in EQ5D5L VAS score represents a higher self-rated quality of life for the individual.](/cms/asset/e1894cba-fb86-4f8f-9e36-3d9d8a4376c2/iere_a_2334220_f0001a_oc.jpg)
Figure 2. (a) Activation responses to the activation questionnaires from the active treatment group in the pre-trial survey and post-trial surveys. An increase in the number of ‘yes’ responses indicates better health engagement for the individual. (b) Activation responses to the activation questionnaires from the control group in the pre-trial survey and post-trial surveys. An increase in the number of ‘yes’ responses indicates better health engagement for the individual.
![Figure 2. (a) Activation responses to the activation questionnaires from the active treatment group in the pre-trial survey and post-trial surveys. An increase in the number of ‘yes’ responses indicates better health engagement for the individual. (b) Activation responses to the activation questionnaires from the control group in the pre-trial survey and post-trial surveys. An increase in the number of ‘yes’ responses indicates better health engagement for the individual.](/cms/asset/3023c3cd-b599-48c7-a33d-a76470c01306/iere_a_2334220_f0002a_oc.jpg)
Table 1. The questions relating to engagement in the survey completed by participants in the control and active treatment groups.